LASIX Trademark

Trademark Overview

On Monday, May 24, 2021, a trademark application was filed for LASIX with the United States Patent and Trademark Office. The USPTO has given the LASIX trademark a serial number of 90731372. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, May 8, 2025. This trademark is owned by Validus Pharmaceuticals LLC. The LASIX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Drug delivery devices, namely, injectors for furosemide, sold filled

Drug delivery devices sold empty, namely, reusable injectors for furosemide
lasix

General Information

Serial Number90731372
Word MarkLASIX
Filing DateMonday, May 24, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, May 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements

Goods and ServicesDrug delivery devices, namely, injectors for furosemide, sold filled
Goods and ServicesDrug delivery devices sold empty, namely, reusable injectors for furosemide

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 19, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameValidus Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameValidus Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Monday, August 30, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, May 27, 2021NEW APPLICATION ENTERED
Tuesday, June 1, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, August 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 26, 2021ASSIGNED TO LIE
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Monday, February 7, 2022NON-FINAL ACTION WRITTEN
Monday, February 7, 2022NON-FINAL ACTION E-MAILED
Monday, February 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 4, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 4, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 11, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 11, 2023SOU EXTENSION 1 FILED
Tuesday, April 11, 2023SOU EXTENSION 1 GRANTED
Thursday, April 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 27, 2023SOU EXTENSION 2 FILED
Wednesday, September 27, 2023SOU EXTENSION 2 GRANTED
Friday, September 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024SOU TEAS EXTENSION RECEIVED
Monday, May 6, 2024SOU EXTENSION 3 GRANTED
Tuesday, May 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2024SOU EXTENSION 4 FILED
Thursday, November 7, 2024SOU TEAS EXTENSION RECEIVED
Friday, November 29, 2024SOU EXTENSION 4 GRANTED
Friday, November 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 7, 2025SOU EXTENSION 5 FILED
Wednesday, May 7, 2025SOU TEAS EXTENSION RECEIVED
Thursday, May 8, 2025SOU EXTENSION 5 GRANTED
Thursday, May 8, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024SOU EXTENSION 3 FILED

Related Keywords

lasix furosemide sold drug injectors namely delivery devices reusable filled empty